Histamine: New thoughts about a familiar mediator

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 2, 2011, Pages 189-197

  Jones, B L ^a,b,c   Kearns, G L ^a,b,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; AMINE OXIDASE (COPPER CONTAINING); CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; THIOPERAMIDE;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BASOPHIL; CD4+ T LYMPHOCYTE; CHEMOTAXIS; DNA POLYMORPHISM; DRUG BINDING; DRUG MECHANISM; HUMAN; IMMUNOMODULATION; INFLAMMATION; MAST CELL; MEDIATOR; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MOTILITY;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; HISTAMINE; HUMANS; HYPERSENSITIVITY; INFLAMMATION; POLYMORPHISM, GENETIC; RECEPTORS, HISTAMINE;

EID: 78951495581     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.256     Document Type: Article

References (55)

1. Emanuel, M.B. Histamine and the antiallergic antihistamines: a history of their discoveries. Clin. Exp. Allergy 29 (suppl. 3), 1-11; discussion 12 (1999).
2. Micromedex. Vol. DRUGDEX® Tradename List http://www.thomsonhc.com/ hcs/librarian.
3. Vernacchio, L., Kelly, J.P., Kaufman, D.W. & Mitchell, A.A. Cough and cold medication use by US children, 1999-2006: results from the Slone survey. Pediatrics 122, E323-e329 (2008).
4. Zachry, W.M. 3rd, Shepherd, M.D., Hinich, M.J., Wilson, J.P., Brown, C.M. & Lawson, K.A. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am. J. Health. Syst. Pharm. 59, 42-49 (2002).
5. Infant deaths associated with cough and cold medications-two states, 2005. MMWR Morb. Mortal. Wkly. Rep. 56, 1-4 (2007).
6. MacGlashan, D. Jr. Histamine: a mediator of inflammation. J. Allergy Clin. Immunol. 112, S53-S59 (2003).
7. Jutel, M., Blaser, K. & akdis, C.A. Histamine in allergic inflammation and immune modulation. Int. Arch. Allergy Immunol. 137, 82-92 (2005).
8. Schmelz, M., Schmidt, R., Bickel, A., Handwerker, H.O. & Torebjörk, H.E. Specific C-receptors for itch in human skin. J. Neurosci. 17, 8003-8008 (1997).
9. Clough, G.F., Bennett, A.R. & Church, M.K. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br. J. Dermatol. 138, 806-814 (1998).
10. Golightly, L.K. & Greos, L.S. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs 65, 341-384 (2005).
11. Kunzmann, S.et al. Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: potential role of histamine in airway remodeling. J. Allergy Clin. Immunol. 119, 1398-1407 (2007).
12. Akdis, C.A. & Blaser, K. Histamine in the immune regulation of allergic inflammation. J. Allergy Clin. Immunol. 112, 15-22 (2003).
13. Akdis, C.A. & Simons, F.E. Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. 533, 69-76 (2006).
14. Lippert, U.et al. Human skin mast cells express H2 and H4, But not H3 receptors. J. Invest. Dermatol. 123, 116-123 (2004).
15. Milligan, G., Bond, R.A. & Lee, M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16, 10-13 (1995).
16. Li, H., Burkhardt, C., Heinrich, U.R., Brausch, I., Xia, N. & förstermann, U. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 107, 2348-2354 (2003). (Pubitemid 36578507)
17. Birklein, F., Claus, D., Riedl, B., Neundörfer, B. & Handwerker, H.O. Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy. Muscle Nerve 20, 1389-1395 (1997).
18. Dvorak, M., Watkinson, A., McGlone, F. & Rukwied, R. Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm. Res. 52, 238-245 (2003).
19. Weiss, S., Robb, G.P. & Blumbgart, H.L. The velocity of blood flow in health and disease as measured by the effect of histamine on the minute vessels. Am. Heart J. 4, 664 (1929).
20. Del Valle, J. & Gantz, I. Novel insights into histamine H2 receptor biology. Am. J. Physiol. 273, G987-G996 (1997).
21. Seligmann, B.E., Fletcher, M.P. & Gallin, J.I. Histamine modulation of human neutrophil oxidative metabolism, Locomotion, Degranulation, And membrane potential changes. J. Immunol. 130, 1902-1909 (1983).
22. Jutel, M.et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425 (2001).
23. Lovenberg, T.W.et al. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 55, 1101-1107 (1999).
24. Arrang, J.M., Garbarg, M. & Schwartz, J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302, 832-837 (1983).
25. Hancock, A.A. H3 receptor antagonists/inverse agonists as anti-obesity agents. Curr. Opin. Investig. Drugs 4, 1190-1197 (2003).
26. Fox, G.B.et al. Two novel and selective nonimidazole H3 receptor antagonists a-304121 and a-317920: II. In vivo behavioral and neurophysiological characterization. J. Pharmacol. Exp. Ther. 305, 897-908 (2003).
27. Suzuki, S., Takeuchi, K. & Majima, Y. Localization and function of histamine H3 receptor in the nasal mucosa. Clin. Exp. Allergy 38, 1476-1482 (2008).
28. Hofstra, C.L., Desai, P.J., Thurmond, R.L. & Fung-Leung, W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305, 1212-1221 (2003).
29. Gutzmer, R., Mommert, S., Gschwandtner, M., Zwingmann, K., Stark, H. & Werfel, T. The histamine H4 receptor is functionally expressed on T(H)2 cells. J. Allergy Clin. Immunol. 123, 619-625 (2009).
30. De Esch, I.J., Thurmond, R.L., Jongejan, A. & Leurs, R. The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol. Sci. 26, 462-469 (2005).
31. Thurmond, R.L.et al. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 309, 404-413 (2004).
32. Dunford, P.J., O'Donnell, N., Riley, J.P., Williams, K.N., Karlsson, L. & Thurmond, R.L. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J. Immunol. 176, 7062-7070 (2006).
33. Guajardo, J.R.et al. Altered gene expression profiles in nasal respiratory epithelium reflect stable versus acute childhood asthma. J. Allergy Clin. Immunol. 115, 243-251 (2005).
34. Dunford, P.J., Williams, K.N., Desai, P.J., Karlsson, L., McQueen, D. & Thurmond, R.L. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J. Allergy Clin. Immunol. 119, 176-183 (2007).
35. Yamaura, K., Oda, M., Suwa, E., Suzuki, M., Sato, H. & Ueno, K. Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J. Toxicol. Sci. 34, 427-431 (2009).
36. Sasaki, Y.et al. Lack of association between atopic asthma and polymorphisms of the histamine H1 receptor, Histamine H2 receptor, And histamine N-methyltransferase genes. Immunogenetics 51, 238-240 (2000).
37. García-Martín, E., Ayuso, P., Luengo, A., Martínez, C. & agúndez, J.A. Genetic variability of histamine receptors in patients with Parkinson's disease. BMC Med. Genet. 9, 15 (2008).
38. Yu, B.et al. Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis. Br. J. Dermatol. 162, 1038-1043 (2010).
39. Wiedemann, P., Bönisch, H., Oerters, F. & Brüss, M. Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations. J. Neural Transm. 109, 443-453 (2002).
40. Rangachari, P.K. The fate of released histamine: reception, Response and termination. Yale J. Biol. Med. 71, 173-182 (1998).
41. Yan, L., Galinsky, R.E., Bernstein, J.A., Liggett, S.B. & Weinshilboum, R.M. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics 10, 261-266 (2000). (Pubitemid 30242742)
42. Chen, G.L.et al. Genotype-phenotype correlation for histamine N-methyltransferase in a Chinese Han population. Clin. Chim. Acta 334, 179-183 (2003).
43. Preuss, C.V.et al. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol. Pharmacol. 53, 708-717 (1998).
44. Chen, G.L.et al. Histamine N-methyltransferase gene polymorphisms in Chinese and their relationship with enzyme activity in erythrocytes. Pharmacogenetics 13, 389-397 (2003).
45. Deindl, P.et al. No association of histamine-N-methyltransferase polymorphism with asthma or bronchial hyperresponsiveness in two German pediatric populations. Pediatr. Allergy. Immunol. 16, 40-42 (2005).
46. Shilpy, S., Deepti, M., Singh, T. & Balaram, G. Lack of association of histamine- N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population. J. Hum. Genet. 50, 611-617 (2005).
47. Kennedy, M.J.et al. Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children. Pharmacotherapy 28, 1495-1501 (2008).
48. Hon, Y.Y., Jusko, W.J., Spratlin, V.E. & Jann, M.W. Altered methylprednisolone pharmacodynamics in healthy subjects with histamine N-methyltransferase C314T genetic polymorphism. J. Clin. Pharmacol. 46, 408-417 (2006).
49. Schwelberger, H. Diamine oxidase (DaO) enzyme and gene. In Histamine: Biology and Medical Aspects (ed. Falus, A.) (SpringMed Publishing, Budapest, Hungary, 2004).
50. Maintz, L., Benfadal, S., Allam, J.P., Hagemann, T., Fimmers, R. & Novak, N. Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. J. Allergy Clin. Immunol. 117, 1106-1112 (2006).
51. Raithel, M., Küfner, M., Ulrich, P. & Hahn, E.G. The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. Inflamm. Res. 48 (suppl. 1), S75-S76 (1999).
52. Petersen, J., Drasche, A., Raithel, M. & Schwelberger, H.G. Analysis of genetic polymorphisms of enzymes involved in histamine metabolism. Inflamm. Res. 52 (suppl. 1), S69-S70 (2003).
53. Petersen, J., Raithel, M. & Schwelberger, H.G. Characterisation of functional polymorphisms of the human diamine oxidase gene. Inflamm. Res. 54 (suppl. 1), S58-S59 (2005).
54. García-Martin, E.et al. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J. Gastroenterol. 12, 615-620 (2006).
55. Ercan-Sencicek, A.G.et al. L-Histidine decarboxylase and Tourette's syndrome. N. Engl. J. Med. 362, 1901-1908 (2010).